Display options
Filter resources
Text Availability
Article type
Publication date
Showing 1 to 12 of 354 entries
Sorted by: Best Match Show Resources per page
[Treatment of febrile episodes in the neutropenic subject: use of the combination of amikacin-colistin-trimethoprim-sulphamethoxazole].

La Nouvelle presse medicale

Marty M, Gisselbrecht C, Samson-Lepors MJ.
PMID: 537897
Nouv Presse Med. 1979 Oct 31;8(42):3465-8.

No abstract available.

Treatment of relapsed and refractory Hodgkin's disease with high dose chemotherapy and autologous bone marrow transplantation.

Nouvelle revue francaise d'hematologie

Brice P, Gisselbrecht C, Ferme C, Lepage E, Baruchel A, Marolleau JP, Gerota O, Boiron M.
PMID: 1956765
Nouv Rev Fr Hematol. 1991;33(3):267-72.

Despite combination of chemotherapy and radiotherapy, some patients with refractory or relapsed Hodgkin's disease (HD) have a bad prognosis. We performed high dose chemotherapy (HDCT) (BCV regimen) with autologous bone marrow transplantation (ABMT) in 26 patients with advanced HD....

Autoimmune hemolytic anemia disclosing Hodgkin's disease associated with Castleman's disease.

Nouvelle revue francaise d'hematologie

Brice P, Marolleau JP, D'Agay MF, Epardeau B, Gisselbrecht C.
PMID: 1956766
Nouv Rev Fr Hematol. 1991;33(3):273-4.

A man was admitted for severe autoimmune hemolytic anemia with a mediastinal mass. He required corticosteroid treatment, which altered the first histological examination. Laparosplenectomy was performed and all histological sections were negative, but the hemolytic anemia was not improved....

The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomas.

The European respiratory journal

Tredaniel J, Brice P, Lepage E, Bris C, Marolleau JP, Ferme C, Hennequin C, Fermand JP, Frija J, Gisselbrecht C.
PMID: 1559581
Eur Respir J. 1992 Feb;5(2):170-3.

The chest radiographs of 252 patients with aggressive non-Hodgkin's lymphoma, prospectively treated according to one of three protocols of combination chemotherapy, were reviewed to determine the incidence and prognostic significance of mediastinal abnormalities following treatment. Residual mediastinal masses were...

Successful treatment of adult acute lymphoblastic leukemia after relapse with prednisone, intermediate-dose cytarabine, mitoxantrone, and etoposide (PAME) chemotherapy.


Milpied N, Gisselbrecht C, Harousseau JL, Sebban C, Witz F, Troussard X, Gratecos N, Michallet M, LeBlond V, Auzanneau G.
PMID: 2386891
Cancer. 1990 Aug 15;66(4):627-31. doi: 10.1002/1097-0142(19900815)66:4<627::aid-cncr2820660404>3.0.co;2-0.

Thirty-nine patients with relapsed acute lymphoblastic leukemia (ALL) and four with primarily refractory ALL were treated with a regimen that included cytarabine 1 gm/m2 (2-hour infusion) twice daily days 1 to 5, mitoxantrone 12mg/m2 daily days 1 to 5,...

Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the lung and stomach.

Cancer treatment reports

Cazap EL, Gisselbrecht C, Smith FP, Estevez RA, Alvarez CA, Lagarde C, Hannois A, Ahmed S, Schein PS, Woolley PV.
PMID: 3524826
Cancer Treat Rep. 1986 Jun;70(6):781-3.

A combination of 5-FU (600 mg/m2 on Days 1 and 8), doxorubicin (40 mg/m2 on Day 1), and cisplatin (75 mg/m2 on Day 1) has been used for treatment of 31 patients with advanced measurable adenocarcinoma of the lung...

Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Bosly A, Coiffier B, Gisselbrecht C, Tilly H, Auzanneau G, Andrien F, Herbrecht R, Legros M, Devaux Y, Jaubert J.
PMID: 1383435
J Clin Oncol. 1992 Oct;10(10):1615-23. doi: 10.1200/JCO.1992.10.10.1615.

PURPOSE: Of the 737 patients with aggressive lymphoma who were treated with the LNH-84 regimen, 244 with progressive disease after complete remission or partial response were analyzed retrospectively to determine the influence of intensive chemotherapy with bone marrow transplantation...

Interleukin-2 after autologous bone marrow transplantation as consolidative immunotherapy against minimal residual disease.

Nouvelle revue francaise d'hematologie

Bosly A, Brice P, Humblet Y, Doyen C, Faille A, Chatelain B, Franks C, Gisselbrecht C, Symann M.
PMID: 2349079
Nouv Rev Fr Hematol. 1990;32(1):13-6.

Recipients of autologous BMT demonstrate clinically significant immune deficiency, particularly involving the T lymphocytes. While quantitatively the immune system generally returns to normal during the first 3 months, there is a prolonged delay in the recovery of qualitative immune...

[Neuromeningeal localizations in non-Hodgkin's lymphomas in adults].

La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris

Harousseau JL, Vallantin X, Tricot G, Gisselbrecht C, Jacquillat C.
PMID: 6301049
Sem Hop. 1983 Jan 27;59(4):221-5.

A total of 483 adult patients with non-leukemic non-Hodgkin lymphomas (NHL) were reviewed for neuromeningeal (NM) involvement. NM involvement was found in 20 patients (4,1%). Presenting complaints were mainly headache (9 cases) or diplopia (8 cases). Cranial nerve palsies...

Chemotherapy of carcinomas of the digestive tract.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

Gisselbrecht C, Belpomme D, Mignot L, Marty M, Mathé G, Boiron M.
PMID: 6799999
Recent Results Cancer Res. 1982;80:296-302. doi: 10.1007/978-3-642-81685-7_47.

Adjuvant chemotherapy trials in gastric and colorectal carcinomas are reviewed and no clear benefit from such treatment could be observed. To improve existing chemotherapy regimens, several pilot studies were performed in 95 gastric cancer and 85 colorectal carcinomas patients....

[Current advances in cancer immunotherapy (author's transl)].

La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris

Belpomme D, Marty M, Gisselbrecht C, Mignot L, Pujade-Lauraine E.
PMID: 6270825
Sem Hop. 1981 Oct 8-15;57(37):1547-56.

Immunotherapy is still considered as an important therapeutic method in oncology. Experimental basis do exist which support the individualization of several distinct conditions of immunomodulation, some of them being associated with a therapeutic benefit. Numerous immunomodulation molecules or derivatives...

[Acanthocytosis in cirrhosis. Report of four cases and review of the literature (author's transl)].

Gastroenterologie clinique et biologique

Gisselbrecht C, Metreau JM, Dhumeaux D, Dreyfus B.
PMID: 913960
Gastroenterol Clin Biol. 1977 Aug-Sep;1(8):621-8.

No abstract available.

Showing 1 to 12 of 354 entries